Navigation Links
ChemImage Scientists Present Latest Developments for in vitro Detection of Colorectal Cancer Using Raman Molecular Imaging (RMI) at International Conference Focused on Biomedical Applications of Raman Spectroscopy
Date:8/19/2014

NEW YORK, Aug. 19, 2014 /PRNewswire-iReach/ -- ChemImage founder and CTO, Patrick J. Treado, PhD, will present a scientific poster describing an innovative diagnostic procedure for the detection of colorectal cancer during the SPEC 2014: Shedding New Light on Disease (SPEC) conference in Krakow, Poland.

Dr. Treado's poster entitled, "Development of in vitro Diagnostics for Detection of Colorectal Cancer Using Raman Molecular Imaging" will be discussed during the conference poster session on Tuesday, August 19, 2014 from 6:30 – 8:00pm.  The scientific poster presents the results of a study performed by scientists at ChemImage, in collaboration with urology and gastroenterology clinicians, on the development of in vitro diagnostic (IVD) Raman assays focused on colorectal cancer detection. The results of these ongoing clinical studies will be presented including discussion of the study design, the underlying basis of discrimination and advantages provided by RMI.

"I am very excited to present our findings at 2014 SPEC," said Patrick J. Treado, Chief Technology Officer at ChemImage. "I look forward to sharing the results of our research with thought leaders in the Raman spectroscopy community."

SPEC 2014 is an international conference series aiming to bring together clinicians and scientists who have joined forces in the quest for novel biomedical applications of Infrared and Raman spectroscopy to improve patient care. Due to its unique fingerprinting capability, Raman spectroscopy plays a significant role in histopathology, cytology, biopsy targeting, surgical targets, and treatment monitoring and drug studies. The conference highlights further advances in state of the art and emerging biomedical applications of Raman Spectroscopy, while critically reviewing the challenges in the context of other emerging technologies.
'/>"/>

SOURCE ChemImage Corporation
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Five Sangamo Scientists Recognized By Thomson Reuters Among Most Highly Cited Researchers Worldwide Of 2014
2. Scientists at HerbalScience Develop a Synergistic Method to Fight Antibiotic Resistant Bacteria
3. Made in IBM Labs: Scientists Turn Data into Disease Detective to Predict Dengue Fever and Malaria Outbreaks
4. Absorption Systems Scientists Publish Peer-reviewed Paper on a Key Drug Transporter
5. New Workflow to Provide Scientists with Tools That Enable Single Cell Analysis for Oncology, Immunology and Stem Cell Research
6. NYU-Poly Nano Scientists Reach the Holy Grail in Label-Free Cancer Marker Detection: Single Molecules
7. From Autism to Diabetes to Parkinsons Disease: Pew Funds 22 Early-Career Scientists to Take Calculated Risks
8. Tucson Symposium attracts over 450 global scientists focused on personalized healthcare
9. Janssen Neuroscientists and Colleagues Challenge Healthcare Industry to Create Integrated Approaches to Healthcare Innovation in Newly Published Article
10. Harrington Discovery Institute at University Hospitals Case Medical Center Announces Grant Funding to Physician-Scientists at Major Academic Medical Centers to Support New Drug Development
11. South Korean lawmakers one step from rigorous new system for stem cell Advancement: scientists, physicians and patients applaud, urge lawmakers to complete The Job
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... , Oct. 22, 2014 WHEN: Wednesday, ... Online, complimentary registration available at: http://bit.ly/1yStiU9 ... Archana Vidyasekar and Visionary Innovation Research Group ... wireless electricity, self-assembling materials, nanobots and flexible ... which will transform our lives in the ...
(Date:10/22/2014)... JOLLA, Calif. , Oct. 22, 2014 ... RGLS ), a biopharmaceutical company leading the ... microRNAs, today announced that it has demonstrated ... an ongoing clinical study evaluating RG-101, a ... the treatment of hepatitis C virus infection ...
(Date:10/20/2014)... , Oct. 20, 2014  Luoxis Diagnostics, ... MKT: AMPE), today announced that its academic collaborators ... and research potential for its novel RedoxSYS Diagnostic ... (ORP) in the body in response to injury ... of ORP as a clinical marker will be ...
Breaking Medicine Technology:Futuristic Technologies That Will Transform Our World Beyond 2030 2Futuristic Technologies That Will Transform Our World Beyond 2030 3Futuristic Technologies That Will Transform Our World Beyond 2030 4A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 2A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 3A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 4A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 5A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 6A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 7A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 8Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 2Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 3Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 4Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 5
... to Advance for Treatment of AllergySAN DIEGO , ... focused on the development of novel Toll-Like Receptor 8 ... inflammatory diseases, announced today that it has initiated a ... TLR8 agonist for the treatment of allergic rhinitis. The ...
... Percent of Newly Diagnosed Patients Receive a Drug Within ... New Report from Decision ResourcesWALTHAM, Mass., April 15 ... the world,s leading research and advisory firms focusing on ... that less than 30 percent of their use of ...
Cached Medicine Technology:VentiRx Pharmaceuticals Initiates Phase I Clinical Trial of VTX-1463, a Novel TLR8 Agonist for the Treatment of Allergic Rhinitis 2Surveyed Neurologists Anticipate That Less Than 30 Percent of Their Use of Emerging Oral Agents in Multiple Sclerosis Will be in the First Line 2Surveyed Neurologists Anticipate That Less Than 30 Percent of Their Use of Emerging Oral Agents in Multiple Sclerosis Will be in the First Line 3
(Date:10/22/2014)... TUESDAY, Oct. 21, 2014 (HealthDay News) -- The ... passengers arriving from Ebola-affected nations of West Africa ... screen them for infection with the virus. ... Jeh Johnson noted that 94 percent of air ... land at one of these five airports -- ...
(Date:10/22/2014)... 22, 2014 During the Western United ... supply runs dangerously low, Southern Oregon’s water is proving ... despite the lowest mountain snow pack on record in ... and early autumn.* That was the observation of journalist-hikers ... book “Hiking Southern Oregon,” during an interview with water ...
(Date:10/22/2014)... Lintelus, Inc., an event software provider, ... Sales, will be speaking on the subject of “Event ... October 28, at the Holiday Inn in New York ... well as a Tech Demo at 12:45pm, to educate ... more engaging event experience. , The Annual Meetings Technology ...
(Date:10/22/2014)... Two sisters in high school have developed ways to ... Krishen use electronic stethoscopes, which electronically amplify body sounds, ... or heartbeats. Ilina, a senior at Port Huron ... way to detect early lung damage in people exposed ... recorded one breath cycle each from 16 smokers, 25 ...
(Date:10/22/2014)... HealthDay Reporter TUESDAY, Oct. 21, 2014 ... while working for NBC News in Liberia has cleared ... unit at Nebraska Medical Center in Omaha, where he had been ... A blood test confirmed by the U.S. Centers for Disease Control ... Providence, R.I., NBC News reported Tuesday night. "Recovering ...
Breaking Medicine News(10 mins):Health News:Passengers From Ebola-Affected Countries Must Land at Designated U.S. Airports 2Health News:Passengers From Ebola-Affected Countries Must Land at Designated U.S. Airports 3Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 2Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 3Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 4Health News:Jay Cormier, Sr. Vice President of Sales for Lintelus, Speaks about Event Technology Integration at Meetings Technology Expo in NYC 2Health News:Teen Sisters Develop Ways to Measure Lung, Heart Damage 2Health News:U.S. Cameraman Treated for Ebola 'Free' of the Virus 2Health News:U.S. Cameraman Treated for Ebola 'Free' of the Virus 3
... The American Senior Fitness Association (SFA) has announced ... exercise professionals. Brain Fitness for Older Adults teaches ... incorporate effective cognitive fitness into physical activity programs, ... and mental fitness simultaneously. Details are available at ...
... This approval enables the,company to market its line of ... EU. Orthomimetics, family of products was developed,during a groundbreaking ... Massachusetts Institute of Technology . , ... helps to support the,repair of defects involving both articular ...
... National Ovarian Cancer Coalition,(NOCC) announced that body image | body ... ovarian cancer, will be on display at,the University of ... 23 to,Mar. 21, 2009. , Created ... 23 from 6 p.m. - 9 p.m. The showing ...
... at their disposable a variety of tools to research and compare ... by many cosmetic surgery seekers, followed closely by cost. The surprising ... affordable procedures. , ... Miami, FL (PRWEB) January 14, ...
... 13 Elephant Ensemble Theater, a company that brings free ... tour of The Pirate & the Squid at ... Ronald McDonald House of Long Island is a "home away ... pain of having a sick child in an area hospital. ...
... Scientific Corporation (NYSE: BSX ) will webcast ... quarter and the year ended December 31, 2008 on ... be hosted by Jim Tobin, President and Chief Executive ... Financial Officer.The live webcast and archived replay of this ...
Cached Medicine News:Health News:Brain Fitness Coming to Senior Exercise Classes 2Health News:Orthomimetics Secures CE Mark Approval for Chondromimetic 2Health News:body image body essence Exhibition Opens at University of Miami 2Health News:Savvy Healthcare Consumers Seek Skilled, Safe Cosmetic Surgeons Abroad; Cosmetic Harmony Quickly Becoming Number One Travel Destination 2Health News:Savvy Healthcare Consumers Seek Skilled, Safe Cosmetic Surgeons Abroad; Cosmetic Harmony Quickly Becoming Number One Travel Destination 3Health News:Elephant Ensemble Theater Launches New Tour at the Ronald McDonald House in Long Island 2Health News:Boston Scientific to Webcast Conference Call Discussing Fourth Quarter and 2008 Financial Results 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: